Environmentally induced systemic sclerosis-like disorders.
Haustein
U F
UF
Ziegler
V
V
D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D003095:Collagen Diseases / Q000139:chemically induced* / Q000473:pathology; D004853:Epoxy Resins / Q000009:adverse effects; D006801:Humans; D009784:Occupational Diseases / Q000139:chemically induced*; D011083:Polycyclic Compounds / Q000009:adverse effects; D012595:Scleroderma, Systemic / Q000209:etiology*; D012825:Silicon / Q000009:adverse effects; D012822:Silicon Dioxide / Q000009:adverse effects; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology; D012997:Solvents / Q000009:adverse effects; D014241:Trichloroethylene / Q000009:adverse effects; D014752:Vinyl Chloride / Q000009:adverse effects
D004853:Epoxy Resins; D011083:Polycyclic Compounds; D012997:Solvents; D001761:Bleomycin; D014241:Trichloroethylene; D012822:Silicon Dioxide; D014752:Vinyl Chloride; D012825:Silicon